IL10 and neoplasm: The strong antibody response in this patient, together with their cellular responses, reflected by high Th1 cytokine (IFNγ/IL-10, and TNFα/IL-10) ratios, correlated with the patient’s increase in progression-free survival and tumor reduction [10].